CannabisNewsBreaks

TuesdayJun 16, 2020 12:01 pm

CannabisNewsBreaks – Sugarmade, Inc. (SGMD) Announces Record BudCars Sales Growth as It Gears Up to Open First LA Hub

Sugarmade (OTCQB: SGMD), together with its BudCars Cannabis Delivery Service (“BudCars”), today announced record growth in gross profits and gross profit margins for BudCars sales during the month of May (up 46% on a sequential month-over-month basis). Per the update, the Company continues to experience strong signals during the first half of June, with gross profits growing 9.9% on a week-over-week basis and believes this performance data provides a template for its per unit operational performance anticipated as it prepares for next month’s launch of its first Los Angeles hub. “As we gear up to open our first new hub…

Continue Reading

MondayJun 15, 2020 12:12 pm

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Expands Agreement with Stillwater Brands to Launch RIPPLE Suite of Products

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, today announced the expansion of its exclusive licensing agreement with Colorado-based Stillwater Brands, under which it will be rolling out the powerful RIPPLE suite of products in Canada, including RIPPLE Gummies and RIPPLE QuickSticks. According to the update, TGOD leveraged Stillwater's proprietary technology to launch its first Cannabis 2.0 product at the end of March – TGOD Infuser 10mg THC – which quickly became one of the top selling SKUs within the beverage category across the country. Given the first product’s success, TGOD has…

Continue Reading

MondayJun 15, 2020 10:52 am

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Strategic Board Appointment of Canopy Growth CFO Mike Lee

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced appointment of Canopy Growth Corporation ("Canopy Growth") (TSX: WEED), (NYSE: CGC) Chief Financial Officer Mike Lee to its Board of Directors (the "Board"). According to the update, the Company expects that Lee's experience at Canopy Growth, Constellation Brands, Inc. and other leading consumer packaged goods and beverage companies will help strengthen its strategic execution as it continues to focus on developing a leading global cannabis portfolio. "Mike's addition to our Board is another sign of our strong and growing relationship with Canopy Growth and Constellation…

Continue Reading

MondayJun 15, 2020 10:08 am

CannabisNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Announces Leadership Change

Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) on Friday announced that Brian Logan is stepping down as chief financial officer, effective July 15, 2020.  Logan has served as GGB’s CFO since January 2019. “On behalf of GGB, I want to thank Brian for his many and significant contributions during his tenure as CFO of the Company,” Randy Whitaker, GGB’s interim CEO, said in the news release. “I wish him the best of luck in his future endeavors.” To view the full press release, visit http://cnw.fm/1s2WU About Green Growth Brands Inc. Green Growth Brands creates remarkable experiences in cannabis. The company's…

Continue Reading

MondayJun 15, 2020 9:41 am

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Provides Corporate Update

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, on Friday provided a corporate update. Since commencing trading on March 2, 2020, the Company has expanded its initiatives and rapidly executed on such initiatives to position it as a leading publicly traded psychedelic medicine company developing novel rapid onset treatments for depression, post-traumatic stress disorder (“PTSD”), and substance-use disorders (“SUD”) via the clinical delivery of ketamine and ketamine-derivatives. In the update, the Company shared its corporate advancements and achievements over the last quarter, which target key segments in…

Continue Reading

FridayJun 12, 2020 10:29 am

CannabisNewsBreaks – Round Meadow Holdings Corp.’s Budtender Awards Contributing and Driving Support in Wake of Senseless Deaths of George Floyd and Others

Round Meadow Holdings’ (“RMH”) Budtender Awards on Thursday sounded off on Instagram regarding events that have led to the senseless deaths of George Floyd, Breonna Taylor, Ahmaud Arbery, and countless others. “We cannot stand by and let this continue, we are motivated to take action for the betterment of our communities. We commit to both immediate and long-term actions as well as providing resources, education, and safe spaces for our community. We will be contributing & driving support towards organizations committed to social justice including @blklivesmatter,” the post stated. To view the full press release, visit http://cnw.fm/WD7zt About Round Meadow…

Continue Reading

ThursdayJun 11, 2020 10:47 am

CannabisNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Embarks on New Phase to Further Capacity and Quality at NUGS Farm

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today provided an update to current and prospective shareholders as it embarks on a new phase of its continued efforts to augment both the quantity and quality of the cannabis produced at NUGS Farm. According to the update, Cannabis Strategic Ventures has been simultaneously targeting operational improvements in production capacity and product quality and has achieved measurable results. The Company has begun a streamlining stage in its grow operations to drive further execution gains, and the grow team at NUGS Farm has begun a process of determining…

Continue Reading

ThursdayJun 11, 2020 9:46 am

CannabisNewsBreaks – Cannabis Global, Inc. (MCTC) Adds Cannabinol (“CBN”) to R&D Effort for Project Varin

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, today announced the expansion of its Project Varin research and development effort to include Cannabinol (“CBN”) under the umbrella of patent pending polymeric nanoparticle and nanofiber technologies developed for Tetrahydrocannabivarin (“THC-V”). According to the update, the first stage of Project Varin produced high load particles of pure THC-V, allowing Cannabis Global to now move into production of commercial quantities. CBN has been added to the production protocol as part of this second phase. "The addition of CBN to the Project Varin production schedule is…

Continue Reading

TuesdayJun 09, 2020 10:28 am

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Announces Retirement of CFO, Names Successor

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a cannabis and hemp branded products company in the U.S., today announced that its Chief Financial Officer, Jon Paul, will be retiring at the end of this month. According to the update, current Vice President of Finance, Nate Pearson, has been identified as his successor, while Paul, following his retirement, will continue in an advisory role to ensure a smooth transition. “Jon has played an integral role in our organization since the day he joined,” Jake Heimark, co-founder and CEO of Plus Products, stated in the news release. “The financial and regulatory environments in…

Continue Reading

MondayJun 08, 2020 11:11 am

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Engages Toronto-based Dalriada to Advance NCE IP Portfolio

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, today announced its selection of Toronto-based Dalriada Drug Discovery Inc. (“Dalriada”) to advance its new chemical entity (“NCE”) IP portfolio as it pertains to ketamine and psilocybin/psilicin molecular scaffolds. According to the update, Dalriada, a leading contract research organization (“CRO”) in the drug discovery space, will lead Champignon’s new drug discovery programs in the NCE arena and further provide integrated R&D support to accelerate the Company’s existing preclinical assets and ongoing development of proprietary delivery platforms. “It is with…

Continue Reading